Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 1 of the last 1 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 51 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
THERANUM from Liège, company number BE1006498130, closed financial year 2025 with a result of € -26,515 after tax. For that financial year THERANUM recorded a gross margin of € -24,978 and equity of € -21,515. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on January 12, 2026.
€ -21,515
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -26,515
Profit after tax over the fiscal year.
€ 19,989
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -26,515.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 44,221
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to THERANUM?
What happened at THERANUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 26,515. Source: NBB ↗
- New establishment in Liège. KBO
- Start of the company according to the CBE. KBO
- XOVELIS SRL became a director. NBB
A new publication or filing at THERANUM? We notify you, reason included.
Follow THERANUMDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of ELYSIA, INVENTURES, NOSHAQ SPIN-OFFS, NOSHAQ VENTURE, NOMAINVEST comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
THERANUMBehind THERANUM is XOVELIS SRL. The shares are held by ELYSIA (51%), INVENTURES (25%), NOSHAQ SPIN-OFFS (16.4%), NOSHAQ VENTURE (16.3%) and NOMAINVEST (11.7%).
Directors
According to the 2025 annual accounts
since 2024
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Rue du Sart-Tilman 375
4031 Liège
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1006.498.130
- VAT number
- BE 1006.498.130
- Registered office
- Rue du Sart-Tilman 375, 4031 Liège
- Names & denominations
- THERANUM
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 27 February 2024
- Peppol
- Active · Active since 4 Dec 2025
- Contact
- [email protected]
- Activities · NACE
Vervaardiging van farmaceutische grondstoffen
Speur- en ontwikkelingswerk op biotechnologisch gebied
Vervaardiging van overige farmaceutische producten